Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

Related Articles by Review for PubMed (Select 17716236)

1.

Increasing the robustness and validity of RNAi screens.

Haney SA.

Pharmacogenomics. 2007 Aug;8(8):1037-49. Review.

PMID:
17716236
2.

RNAi screening for the discovery of novel modulators of human disease.

Seyhan AA, Rya TE.

Curr Pharm Biotechnol. 2010 Nov;11(7):735-56. Review.

PMID:
20420566
3.

RNAi screening: new approaches, understandings, and organisms.

Mohr SE, Perrimon N.

Wiley Interdiscip Rev RNA. 2012 Mar-Apr;3(2):145-58. doi: 10.1002/wrna.110. Epub 2011 Sep 22. Review.

4.

RNA interference in mammals: behind the screen.

Campeau E, Gobeil S.

Brief Funct Genomics. 2011 Jul;10(4):215-26. doi: 10.1093/bfgp/elr018. Review.

PMID:
21791555
5.

RNAi screening comes of age: improved techniques and complementary approaches.

Mohr SE, Smith JA, Shamu CE, Neumüller RA, Perrimon N.

Nat Rev Mol Cell Biol. 2014 Sep;15(9):591-600. doi: 10.1038/nrm3860. Review.

6.

High-throughput screening using siRNA (RNAi) libraries.

Chen M, Du Q, Zhang HY, Wang X, Liang Z.

Expert Rev Mol Diagn. 2007 May;7(3):281-91. Review.

PMID:
17489735
7.

Oncology studies using siRNA libraries: the dawn of RNAi-based genomics.

Sachse C, Echeverri CJ.

Oncogene. 2004 Nov 1;23(51):8384-91. Review.

PMID:
15517020
8.

Cell perturbation screens for target identification by RNAi.

Demir K, Boutros M.

Methods Mol Biol. 2012;910:1-13. doi: 10.1007/978-1-61779-965-5_1. Review.

PMID:
22821589
9.

Genomic screening with RNAi: results and challenges.

Mohr S, Bakal C, Perrimon N.

Annu Rev Biochem. 2010;79:37-64. doi: 10.1146/annurev-biochem-060408-092949. Review.

10.

Cellular phenotyping by RNAi.

Fuchs F, Boutros M.

Brief Funct Genomic Proteomic. 2006 Mar;5(1):52-6. Epub 2006 Feb 23. Review.

11.

Statistical methods for analysis of high-throughput RNA interference screens.

Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, Shanks E, Santoyo-Lopez J, Dunican DJ, Long A, Kelleher D, Smith Q, Beijersbergen RL, Ghazal P, Shamu CE.

Nat Methods. 2009 Aug;6(8):569-75. doi: 10.1038/nmeth.1351. Review.

12.

From sequence to function: using RNAi to elucidate mechanisms of human disease.

Wolters NM, MacKeigan JP.

Cell Death Differ. 2008 May;15(5):809-19. doi: 10.1038/sj.cdd.4402311. Epub 2008 Jan 18. Review.

13.

RNA interference for the identification of disease-associated genes.

Nencioni A, Sandy P, Dillon C, Kissler S, Blume-Jensen P, Van Parijs L.

Curr Opin Mol Ther. 2004 Apr;6(2):136-40. Review. Erratum in: Curr Opin Mol Ther. 2005 Jun;7(3):282.

PMID:
15195924
14.

RNAi screening for therapeutic targets in human malignancies.

Micklem DR, Lorens JB.

Curr Pharm Biotechnol. 2007 Dec;8(6):337-43. Review.

PMID:
18289042
15.

RNA interference: from model organisms towards therapy for neural and neuromuscular disorders.

Buckingham SD, Esmaeili B, Wood M, Sattelle DB.

Hum Mol Genet. 2004 Oct 1;13 Spec No 2:R275-88. Review.

16.

Identifying HIV-1 host cell factors by genome-scale RNAi screening.

Pache L, König R, Chanda SK.

Methods. 2011 Jan;53(1):3-12. doi: 10.1016/j.ymeth.2010.07.009. Epub 2010 Jul 21. Review.

PMID:
20654720
17.

Technique review: how to use RNA interference.

Lehner B, Fraser AG, Sanderson CM.

Brief Funct Genomic Proteomic. 2004 Apr;3(1):68-83. Review.

18.

Discovery of novel targets with high throughput RNA interference screening.

Kassner PD.

Comb Chem High Throughput Screen. 2008 Mar;11(3):175-84. Review.

PMID:
18336211
19.

Functional genomic screening to enhance oncolytic virotherapy.

Mahoney DJ, Stojdl DF.

Br J Cancer. 2013 Feb 5;108(2):245-9. doi: 10.1038/bjc.2012.467. Epub 2012 Nov 20. Review.

20.

[Application of RNAi library to oncology investigation].

Weng DH, Wang SX, Ma D.

Ai Zheng. 2008 Nov;27(11):1229-32. Review. Chinese.

PMID:
19000460
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk